Flarex Suspension/ Drops
NDC Package 82667-010-01

11-digit billing NDC: 82667001001 · Billing unit: ML · 5 ML per package

Package Information

Flarex (fluorometholone acetate) suspension/ dropses is fLAREX (fluorometholone acetate ophthalmic suspension) 0.1% is indicated for use in the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the eye. This formulation utilizes a suspension/ drops delivery system. Marketed by Harrow Eye, Llc, this product is identified by NDC 82667-010 and is authorized under FDA application NDA019079.

Identification & Billing

NDC Package Code
82667-010-01
Package Description
1 BOTTLE, PLASTIC in 1 CARTON / 5 mL in 1 BOTTLE, PLASTIC
Product Code
11-Digit Billing Format
82667001001
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
5 ML
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Flarex
Non-Proprietary Name
Fluorometholone Acetate
Substance Name
Fluorometholone Acetate
Dosage Form
Suspension/ Drops - A suspension which is usually administered in a dropwise fashion.
Administration Route
Ophthalmic - Administration to the external eye.
Active Ingredient(s)
Usage Information
FLAREX (fluorometholone acetate ophthalmic suspension) 0.1% is indicated for use in the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the eye.

Regulatory & Marketing

Labeler Name
Harrow Eye, Llc
Product Type
Human Prescription Drug
FDA Application #
NDA019079
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
03-31-2025
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (82667-010). Click a package code to view its specific billing and regulatory data.

1 BOTTLE, PLASTIC in 1 CARTON / 2.5 mL in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 82667-010-01 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 5 ml in 1 bottle, plastic of Flarex, a human prescription drug labeled by Harrow Eye, Llc. This product is billed per "ML" milliliter and contains an estimated amount of 5 billable units per package. This suspension/ drops is formulated for ophthalmic use and contains fluorometholone acetate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Harrow Eye, Llc on March 31, 2025. The current certification is valid through December 31, 2027.

How is this Harrow Eye, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 82667001001. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 5 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
82667-010-01
11-Digit CMS (5-4-2)
82667-0010-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.